Suppr超能文献

血管肾素在局部生成血管紧张素中的意义。

Significance of vascular renin for local generation of angiotensins.

作者信息

Higashimori K, Gante J, Holzemann G, Inagami T

机构信息

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tenn 37232.

出版信息

Hypertension. 1991 Mar;17(3):270-7. doi: 10.1161/01.hyp.17.3.270.

Abstract

The effects of specific renin inhibitors, angiotensin converting enzyme inhibitors, indomethacin, and prostaglandin I2 analogue on the release of angiotensins from isolated and Krebs-Ringer-perfused rabbit mesenteric arteries were examined. Three different renin inhibitors suppressed release of angiotensins in dose-dependent manners. At the highest concentration (10(-7) M), the inhibitors EMD 52,620, EMD 54,388, and EMD 52,742 induced 46%, 52%, and 48% decreases, respectively, in the basal rate of immunoreactive angiotensin II release. These results provide clear evidence that released angiotensins are produced by the specific action of vascular renin and that the renin inhibitors suppress the vascular renin-angiotensin system as well as the circulating renin-angiotensin system and appear to provide a useful mode for the treatment of hypertension. Nonsulfhydryl angiotensin converting enzyme inhibitors cilazapril and delapril were more effective than captopril, and ramipril was equipotent to captopril, suggesting that the effectiveness of angiotensin converting enzyme inhibitors on the vascular renin-angiotensin system cannot be explained only by its inhibitory effect on angiotensin converting enzyme. Indomethacin, which was reported to suppress angiotensin II release from rat hind limbs, elicited a dose-dependent increase of angiotensin release from rabbit mesenteric arteries. These results suggest that a difference exists in the regulatory mechanisms in the release of angiotensins from diverse vascular beds.

摘要

研究了特异性肾素抑制剂、血管紧张素转换酶抑制剂、吲哚美辛和前列腺素I2类似物对离体并用Krebs-Ringer液灌注的兔肠系膜动脉中血管紧张素释放的影响。三种不同的肾素抑制剂以剂量依赖性方式抑制血管紧张素的释放。在最高浓度(10^(-7) M)时,抑制剂EMD 52,620、EMD 54,388和EMD 52,742分别使免疫反应性血管紧张素II释放的基础速率降低了46%、52%和48%。这些结果提供了明确的证据,即释放的血管紧张素是由血管肾素的特异性作用产生的,并且肾素抑制剂抑制血管肾素-血管紧张素系统以及循环肾素-血管紧张素系统,似乎为高血压的治疗提供了一种有用的模式。非巯基血管紧张素转换酶抑制剂西拉普利和地拉普利比卡托普利更有效,雷米普利与卡托普利等效,这表明血管紧张素转换酶抑制剂对血管肾素-血管紧张素系统的有效性不能仅通过其对血管紧张素转换酶的抑制作用来解释。据报道,吲哚美辛可抑制大鼠后肢血管紧张素II的释放,但它却引起兔肠系膜动脉血管紧张素释放呈剂量依赖性增加。这些结果表明,不同血管床中血管紧张素释放的调节机制存在差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验